Horse Joint Supplement Evidence: What the Science Shows

Joint supplements are widely used in horses but evidence for efficacy varies enormously between products, with welfare implications for both overtreated sound horses and undertreated lame ones.

Key Facts

The equine joint supplement market is worth hundreds of millions annually with minimal regulatory oversight
Glucosamine and chondroitin sulfate have limited evidence in horses, though better evidence exists in humans
Omega-3 fatty acids from marine or plant sources have the strongest evidence for anti-inflammatory effects in horses
Hyaluronic acid oral supplements have limited bioavailability evidence despite theoretical rationale
Few equine joint supplements have been tested in properly controlled clinical trials with objective outcome measures
Intra-articular treatments (injected directly into joints) have much stronger evidence than oral supplements

Welfare Considerations

Joint supplement welfare intersects with evidence-based veterinary practice in complex ways. The welfare risk of false economy is real - owners who believe expensive oral supplements are adequately managing joint pain may delay seeking veterinary investigation of lameness that requires different management. Conversely, owners committed to evidence-based management who avoid supplements may miss the anti-inflammatory benefits that omega-3 supplementation provides. The welfare-appropriate approach requires distinguishing between supplements with reasonable evidence (omega-3s, some nutraceuticals) and those with poor evidence, using supplements as adjuncts to veterinary management rather than substitutes.

What You Can Do

Discuss joint supplement choices with your veterinarian and prioritize products with published trial evidence
Do not use supplements as a substitute for veterinary investigation of lameness - they are adjuncts not treatments
Consider omega-3 fatty acid supplementation as the best-evidenced oral joint health support option
Monitor response to any supplement objectively using gait assessment, not subjective impression
Prioritize veterinary-prescribed treatments (intra-articular, systemic) over supplements for active joint disease